Focusing on profitability, balance‐sheet strength, reasonable valuations (low or moderate P/E relative to growth/ROIC), and an ability to weather downturns. The first section highlights 10 names to “double down” on (i.e. they stand out as “battle‐vetted worth” or high‐quality franchises). The second section lists 5 to consider cutting, primarily because they are either momentum/ETF plays without clear “worth” underpinnings, high exploit with finesse/volatility instruments, or simply lack the hallmarks of strong fundamental bargains.

 

10 to Double Down On

Below are ten individual companies (rather than broad ETFs) that tend to show the classic “worth + quality” metrics: solid balance sheets, healthy margins, sensible valuations (relative to their returns on capital), and business resiliency over cycles.

  1. AGCO (AGCO Corp)
    • What they do: Agricultural equipment (similar space to Deere/CNH).
    • Why it stands out:
      • P/E often in the single‐digits/low double‐digits.
      • Generally strong free cash flow, stable demand for farm machinery over the long run.
      • Solid record of profitability and returns on equity/capital.
  2. MLI (Mueller Industries)
    • What they do: Manufactures copper, aluminum, brass, and plastic products (HVAC, refrigeration, industrial).
    • Why it stands out:
      • Often trades at a very modest P/E despite strong earnings and consistent profitability.
      • Balance sheet tends to be conservative with relatively low debt.
      • Has surprised the market with steady earnings growth in an otherwise cyclical space.
  3. TSM (Taiwan Semiconductor Manufacturing)
    • What they do: World’s leading semiconductor foundry (makes chips for Apple, Nvidia, etc.).
    • Why it stands out:
      • High margins, high ROE, and a dominant global position in advanced chip manufacturing.
      • Typically trades at a reasonable multiple (often mid to high teens P/E) given its moat.
      • Enormous free‐cash‐flow generation, although capex is also high; still, an undisputed leader.
  4. LRCX (Lam Research)
    • What they do: Designs and manufactures semiconductor production equipment.
    • Why it stands out:
      • Strong ROIC, reliable free cash flow, and a leading position in etching/deposition tools.
      • Though semicap equipment is cyclical, Lam’s execution and margins have been outstanding.
      • Typically has run at a below‐market P/E relative to its longer‐term growth.
  5. WMT (Walmart)
    • What they do: Largest brick‐and‐mortar retailer in the U.S.
    • Why it stands out:
      • Often considered a defensive name in downturns due to staple‐like nature of its business.
      • Huge scale, consistent free cash flow, and stable dividend.
      • Valuation isn’t “thorough worth,” but Walmart’s reliability is high.
  6. SIGI (Selective Insurance Group)
    • What they do: U.S. property & casualty insurer.
    • Why it stands out:
      • Insurance can be defensive: stable premiums, especially if underwriting discipline is good.
      • Historically healthy ROE; not typically overleveraged.
      • Can compound book worth over time while trading at a fair multiple.
  7. BRO (Brown & Brown)
    • What they do: Insurance brokerage and agency.
    • Why it stands out:
      • Insurance brokers often earn consistent fee revenue with minimal balance‐sheet risk.
      • Strong margins relative to capital employed; good “steady Eddy” compounding.
      • Often trades at a premium multiple, but for a predictable, high‐ROIC business.
  8. GSK (GSK plc)
    • What they do: Large global pharmaceutical company (vaccines, specialty pharma, consumer health legacy).
    • Why it stands out:
      • Typically runs at a moderate P/E (often low‐ to mid‐teens); dividend produce can be attractive.
      • Balance sheet has been improving after some restructurings/spinoffs.
      • Big pharma often provides defensiveness in downturns due to recurring drug demand.
  9. TGLS (Tecnoglass Inc.)
    • What they do: Architectural glass & window systems (primarily in U.S., though based in Colombia).
    • Why it stands out:
      • Surprisingly high margins and ROE for a building‐products company.
      • Historically trades at a single‐digit P/E despite consistent double‐digit top/bottom line growth.
      • Some cyclical exposure to construction, but TGLS has delivered strong earnings and FCF.
  10. TTEK (Tetra Tech Inc.)
  • What they do: Consulting/engineering services focusing on water, environmental, and infrastructure.
  • Why it stands out:
    • Demand can be relatively steady (infrastructure projects, government contracts, environmental).
    • Healthy balance sheet, above‐average ROIC for a consulting firm.
    • P/E can run higher than “thorough worth,” but TTEK’s niche and consistency justify a premium.

5 to Consider Cutting

These five are either purely momentum/growth ETFs, high‐exploit with finesse instruments, or companies/ETFs that do not obviously check the “thorough fundamental worth” and “downturn resilience” boxes.

  1. VGT (Vanguard Information Technology ETF)
    • Why cut:
      • A broad, tech‐heavy ETF that largely overlaps with the high‐fliers in the NASDAQ/QQQ.
      • If your aim is to avoid “hopium” growth bets, VGT is essentially a momentum basket.
  2. TMF (Direxion Daily 20‐Year Treasury Bull 3X)
    • Why cut:
      • A utilized effectively interest‐rate vehicle, not a true “fundamental” equity.
      • Returns hinge on bond‐produce moves, making it quite volatile—few fundamental underpinnings.
  3. CQQQ (Invesco China Technology ETF)
    • Why cut:
      • Another thematic, growth‐oriented ETF with exposure to regulatory and macro risk in China tech.
      • Not a single “worth” stock; more a basket of higher‐volatility Chinese internet/gaming/e‐com names.
  4. XMMO (Invesco S&P MidCap Momentum ETF)
    • Why cut:
      • By definition, a momentum strategy—chasing recent performance rather than fundamental worth.
      • May be prone to larger drawdowns when market sentiment reverses.
  5. MTCH (Match Group)
    • Why cut:
      • While it is profitable, the valuation is historically quite rich relative to its growth.
      • More a high‐multiple, “tech‐ish” growth story with less of that defensive, stable cash‐flow profile.
      • If the market turns, consumer‐discretionary web platforms can be volatile compared to “worth” names.

Honorable Mentions (Others You Might Like but Didn’t Make the Top 10)

  • FLEX (Flex Ltd.): A contract‐manufacturing/EMS provider, often at a low P/E. Attractive in many worth screens, though it can be cyclical.
  • NTES (NetEase): Strong margins, big net cash, but has China regulatory risk. Fundamentally reliable but country risk is the caveat.
  • HOLX (Hologic): Diagnostic/medical device name; stable margins, but typically trades at a moderate‐to‐high multiple relative to growth.
  • BSX (Boston Scientific): Another med‐tech giant with good long‐term growth, though valuation can run hot.

All told, the 10 “double down” picks above have historically demonstrated more balance‐sheet strength, free‐cash‐flow generation, and defensive or at least durable business models—factors that can help them stand out “even in a downturn.” Meanwhile, the five “cut” recommendations lean more speculative or momentum‐driven rather than time‐vetted fundamental worth.